Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Employees - 5635,
CEO - Mr. Franco Stevanato,
Sector - Healthcare,
Country - IT,
Market Cap - 5.45B
Altman ZScore(max is 10): 2.45, Piotroski Score(max is 10): 5, Working Capital: $386463000, Total Assets: $2213843000, Retained Earnings: $0, EBIT: 157307565, Total Liabilities: $2213843000, Revenue: $1087241030
AryaFin Target Price - $-16.09 - Current Price $20.76 - Analyst Target Price $25.84
Ticker | STVN |
Index | - |
Curent Price | 20.76 |
Change | 0.97% |
Market Cap | 5.45B |
Average Volume | 512.42K |
Income | 124.25M |
Sales | 1.19B |
Book Value/Share | 5.41 |
Cash/Share | 0.33 |
Dividend Est | 0.04 (0.21%) |
Dividend TTM | 0.06 (0.28%) |
Dividend Ex-Date | Jun 04, 2024 |
Employees | - |
Moving Avg 20days | -1.70% |
Moving Avg 50days | 3.51% |
Moving Avg 200days | -4.51% |
Shares Outstanding | 49.60M |
Earnings Date | Nov 05 BMO |
Inst. Ownership | 19.91% |
Price/Earnings | 44.92 |
Forwad P/E | 36.59 |
PE Growth | 8.25 |
Price/Sales | 4.60 |
Price/Book | 3.84 |
Price/Cash | 62.64 |
Price/FCF | - |
Quick Ratio | 1.21 |
Current Ratio | 1.81 |
Debt/Equity | 0.27 |
Return on Assets | 5.51% |
Return on Equity | 9.42% |
Return on Investment | 6.91% |
Gross Margin | 26.69% |
Ops Margin | 13.87% |
Profit Margin | 10.48% |
RSI | 48.13 |
BETA(β) | 0.58 |
From 52week Low | 25.36% |
From 52week High | -40.22% |
EPS | 0.46 |
EPS next Year | 0.57 |
EPS next Qtr | 0.19 |
EPS this Year | -18.68% |
EPS next 5 Year | 5.45% |
EPS past 5 Year | 37.59% |
Sales past 5 Year | 18.75% |
EPS Y/Y | -22.61% |
Sales Y/Y | 5.26% |
EPS Q/Q | -22.30% |
Sales Q/Q | 3.38% |
Sales Surprise | 1.19% |
EPS Surprise | -4.95% |
ATR(14) | 1.10 |
Perf Week | -11.02% |
Perf Month | 5.81% |
Perf Quarter | 2.01% |
Perf Year | -23.82% |
Perf YTD | -23.93% |
Target Price | 25.84 |
AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer